Skip to main content
. 2012 Feb 1;4(1):77–87. doi: 10.3390/cancers4010077

Table 1.

Fotemustine before temozolomide era.

Authors Number of Patients Schedule Toxicity Grade 3–4 Thrombocytopenia and Leucopenia Response Rate
Frenay et al. [15] 38 Standard 23 and 17% of patients 23%
Khayat et al. [16] 8 Intra-arterial 14% of patients 12.5%
Malhaire et al. [17] 22 Standard 2 and 4 patients 50%
Mousseau et al. [18] 34 Standard NA 70%
Boiardi et al. [19] 16 Escalating doses and procarbazine 1 and 1 patients 50%
Fazen-Döner et al. [20] 31 Standard and dacarbazine 1 and 3 patients 54.8%